E. Botti

Massachusetts General Hospital — United States

Immunology and Microbiology · Life Sciences

7h-index283citations33works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psoriasis: Treatment and Pathogenesis(15), Cytokine Signaling Pathways and Interactions(5), Asthma and respiratory diseases(4), T-cell and B-cell Immunology(3), Monoclonal and Polyclonal Antibodies Research(3)

Publications33 total

Virtual inpatient continuity visit to reduce readmissions, establish goals of care and engage palliative care: A feasibility pilot.
JCO Oncology Practice·2023
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy
Expert Opinion on Biological Therapy·2021· 28 citedOpen Access
The role of reflectance confocal microscopy on diagnosis of melanoacanthoma
Actas Dermo-Sifiliográficas·2021· 2 citedOpen Access
A Rare Case of Talcum Powder Pica Induced Pulmonary Talcosis
2021· 1 citedOpen Access
Papel de la microscopia confocal de reflectancia en el diagnóstico del melanoacantoma
Actas Dermo-Sifiliográficas·2021· 2 citedOpen Access
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus
Scientific Reports·2020· 33 citedOpen Access
092 Novel biallelic RIPK4 mutations cause ectodermal dysplasia with cutaneous syndactyly
Journal of Investigative Dermatology·2019
SAT0039 Ll37 up-regulation and anti-ll37 reactivity are shared by psoriasis and psoriatic arthritis patients
Annals of the Rheumatic Diseases·2018Open Access
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo
Oncogene·2017· 22 citedOpen Access
236 Histopathological and immunohistochemical findings in aldara psoriatic mice model after topical application of methotrexate loaded gold nanoparticle: A comparative study
Journal of Investigative Dermatology·2016Open Access
Biomarkers to optimize ustekinumab therapy in psoriatic patients
Ghent University Academic Bibliography (Ghent University)·2015
Pharmacogenetics of psoriasis:<i>HLA-Cw6</i>but not<i>LCE3B/3C</i>deletion nor<i>TNFAIP3</i>polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab
British Journal of Dermatology·2013· 143 cited
Label-free discrimination of cells undergoing apoptosis by hyperspectral confocual reflectance imaging
Journal of the European Optical Society Rapid Publications·2013· 7 citedOpen Access
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis
Clinical Drug Investigation·2013
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis
Cineca Institutional Research Information System (Tor Vergata University)·2012
Anti-inflammatory activity of IKKa in psoriasis explored by ChIP-sequencing
2012
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis
2012
Patients with Moderate to Severe Plaque Psoriasis: One Year after the European Medicines Agency Recommendation of Efalizumab Suspension
Dermatology·2011· 7 cited
Demonstration of novel innate immune cells in psoriasis
Journal of Translational Medicine·2010Open Access
Innate immune function for HLA-Cw6 in psoriasis: reduced expression of HLA-Cw6 facilitates tumour necrosis factor-alpha release due to impaired interaction with inhibitory receptor KIR2DL1
British Journal of Dermatology·2009
page 1 of 2Next →

Frequent Co-authors

Antonio Costanzo(16), Sergio Chimenti(10), Marina Talamonti(9), Giulia Spallone(9), Luca Bianchi(6), Christian Hundhausen(5), Ute Laggner(5), Barbara Marinari(4), F. O. Nestle(4), Pinetti(4), Marco Galluzzo(3), Miriam Teoli(3), Mauro Bavetta(3), Marina Papoutsaki(3), Paola Di Meglio(3), Matthias Marget(3), Rose Mak(3), Roberto Lande(2), Raffaella Palazzo(2), Francesca Spadaro(2)